Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Proteasome: a Nanomachinery of Creative Destruction.

Kudriaeva AA, Belogurov AA.

Biochemistry (Mosc). 2019 Jan;84(Suppl 1):S159-S192. doi: 10.1134/S0006297919140104. Review.

PMID:
31213201
2.

Loading Rate of Exogenous and Autoantigenic Determinants on Major Histocompatibility Complex Class II Mediates Resistance to Multiple Sclerosis.

Mamedov AE, Zakharova MY, Favorova OO, Kulakova OG, Boyko AN, Knorre VD, Vorobieva NA, Khurs EN, Kiselev IS, Baulina NM, Gabibov AG, Belogurov AA.

Dokl Biochem Biophys. 2019 Mar;485(1):115-118. doi: 10.1134/S1607672919020078. Epub 2019 Jun 14.

PMID:
31201628
3.

Probing Surface Membrane Receptors Using Engineered Bacteriophage Bioconjugates.

Lomakin YA, Kaminskaya AN, Stepanov AV, Shmidt AA, Gabibov AG, Belogurov AA Jr.

Bioconjug Chem. 2019 May 15;30(5):1500-1506. doi: 10.1021/acs.bioconjchem.9b00218. Epub 2019 May 6.

PMID:
31021608
4.

Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma.

Stepanov AV, Markov OV, Chernikov IV, Gladkikh DV, Zhang H, Jones T, Sen'kova AV, Chernolovskaya EL, Zenkova MA, Kalinin RS, Rubtsova MP, Meleshko AN, Genkin DD, Belogurov AA Jr, Xie J, Gabibov AG, Lerner RA.

Sci Adv. 2018 Nov 14;4(11):eaau4580. doi: 10.1126/sciadv.aau4580. eCollection 2018 Nov.

5.

Death Receptors: New Opportunities in Cancer Therapy.

Ukrainskaya VM, Stepanov AV, Glagoleva IS, Knorre VD, Belogurov AAJ, Gabibov AG.

Acta Naturae. 2017 Jul-Sep;9(3):55-63.

6.

Analysis of Immunogenicity of Intracellular CTAR Fragments of Epstein-Barr Virus Latent Phase Protein LMP1.

Lomakin YA, Shmidt AA, Bobik TV, Chernov AS, Pyrkov AY, Aleksandrova NM, Okunola DO, Vaskina MI, Ponomarenko NA, Telegin GB, Dubina MV, Belogurov AA Jr.

Bull Exp Biol Med. 2017 Oct;163(6):766-771. doi: 10.1007/s10517-017-3899-3. Epub 2017 Oct 24.

PMID:
29063322
7.

Evolution of catalytic centers of antibodies by virtual screening of broad repertoire of mutants using supercomputer.

Golovin AV, Smirnov IV, Stepanova AV, Zalevskiy AO, Zlobin AS, Ponomarenko NA, Belogurov AA, Knorre VD, Hurs EN, Chatziefthimiou SD, Wilmanns M, Blackburn GM, Khomutov RM, Gabibov AG.

Dokl Biochem Biophys. 2017 Jul;475(1):245-249. doi: 10.1134/S1607672917040019. Epub 2017 Sep 2.

PMID:
28864894
8.

Combinatorial Screening of Peptides, Specific Ligands of Death Receptor DR5.

Ukrainskaya VM, Stepanov AV, Belogurov AA Jr, Gabibov AG.

Bull Exp Biol Med. 2017 Jul;163(3):381-384. doi: 10.1007/s10517-017-3809-8. Epub 2017 Jul 25.

PMID:
28744632
9.

Design of Chemical Conjugate for Targeted Therapy of Multiple Sclerosis Based of Constant Fragment of Human Antibody Heavy Chain and Peptoid Analog of Autoantigen MOG35-55.

Lomakin YA, Stepanov AV, Balabashin DS, Ponomarenko NA, Smirnov IV, Belogurov AA Jr.

Bull Exp Biol Med. 2017 Apr;162(6):777-780. doi: 10.1007/s10517-017-3711-4. Epub 2017 Apr 21.

PMID:
28429225
10.

Microfluidic droplet platform for ultrahigh-throughput single-cell screening of biodiversity.

Terekhov SS, Smirnov IV, Stepanova AV, Bobik TV, Mokrushina YA, Ponomarenko NA, Belogurov AA Jr, Rubtsova MP, Kartseva OV, Gomzikova MO, Moskovtsev AA, Bukatin AS, Dubina MV, Kostryukova ES, Babenko VV, Vakhitova MT, Manolov AI, Malakhova MV, Kornienko MA, Tyakht AV, Vanyushkina AA, Ilina EN, Masson P, Gabibov AG, Altman S.

Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2550-2555. doi: 10.1073/pnas.1621226114. Epub 2017 Feb 15.

11.

Mediators and Biomarkers of Inflammation in Meningitis: Cytokine and Peptidome Profiling of Cerebrospinal Fluid.

Belogurov AA Jr, Ivanova OM, Lomakin YA, Ziganshin RH, Vaskina MI, Knorre VD, Klimova EA, Gabibov AG, Ivanov VT, Govorun VM.

Biochemistry (Mosc). 2016 Nov;81(11):1293-1302.

12.

Robotic QM/MM-driven maturation of antibody combining sites.

Smirnov IV, Golovin AV, Chatziefthimiou SD, Stepanova AV, Peng Y, Zolotareva OI, Belogurov AA Jr, Kurkova IN, Ponomarenko NA, Wilmanns M, Blackburn GM, Gabibov AG, Lerner RA.

Sci Adv. 2016 Oct 19;2(10):e1501695. eCollection 2016 Oct.

13.

Deimination of the myelin basic protein decelerates its proteasome-mediated metabolism.

Kuzina ES, Kudriaeva AA, Glagoleva IS, Knorre VD, Gabibov AG, Belogurov AA.

Dokl Biochem Biophys. 2016 Jul;469(1):277-80. doi: 10.1134/S1607672916040116. Epub 2016 Sep 7.

PMID:
27599511
14.

mRNA expression profile of mouse oligodendrocytes in inflammatory conditions.

Kudriaeva AA, Khaustova NA, Maltseva DV, Kuzina ES, Glagoleva IS, Surina EA, Knorre VD, Belogurov AA Jr, Tonevitsky AG, Gabibov AG.

Dokl Biochem Biophys. 2016 Jul;469(1):264-8. doi: 10.1134/S1607672916040086. Epub 2016 Sep 7.

PMID:
27599508
15.

Erratum to: Heterodimer HLA-DM Fused with Constant Fragment of the Heavy Chain of the Human Immunoglobulin Accelerates Influenza Hemagglutinin Peptide HA306-318 Loading to HLA-DR1.

Mamedov AE, Ponomarenko NA, Belogurov AA Jr, Gabibov AG.

Bull Exp Biol Med. 2016 Jul;161(3):442-446. No abstract available.

PMID:
27520960
16.

Peptidyl Aldehyde Specifically Interacts with Immunosubunit β1i Proteasome: In Vitro and In Vivo Effects.

Kuzina ES, Kudriaeva AA, Maltseva DV, Belogurov AA Jr.

Bull Exp Biol Med. 2016 May;161(1):69-71. doi: 10.1007/s10517-016-3347-9. Epub 2016 Jun 6.

PMID:
27270938
17.

[Expression Of DNA-Encoded Antidote to Organophosphorus Toxins in the Methylotrophic Yeast Pichia Pastoris].

Terekhov SS, Bobik TV, Mokrushina YA, Stepanova AV, Aleksandrova NM, Smirnov IV, Belogurov AA, Ponomarenko NA, Gabibov AG.

Prikl Biokhim Mikrobiol. 2016 Mar-Apr;52(2):184-92. Russian.

PMID:
27266247
18.

Heterodimer HLA-DM Fused with Constant Fragment of the Heavy Chain of the Human Immunoglobulin Accelerates Influenza Hemagglutinin HA306-318 Loading to HLA-DR1.

Mamedov AE, Ponomarenko NA, Belogurov AA Jr, Gabibov AG.

Bull Exp Biol Med. 2016 May;161(1):92-5. doi: 10.1007/s10517-016-3353-y. Epub 2016 Jun 6. Erratum in: Bull Exp Biol Med. 2016 Jul;161(3):442-6.

PMID:
27265131
19.

The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids.

Ziganshin RH, Ivanova OM, Lomakin YA, Belogurov AA Jr, Kovalchuk SI, Azarkin IV, Arapidi GP, Anikanov NA, Shender VO, Piradov MA, Suponeva NA, Vorobyeva AA, Gabibov AG, Ivanov VT, Govorun VM.

Mol Cell Proteomics. 2016 Jul;15(7):2366-78. doi: 10.1074/mcp.M115.056036. Epub 2016 May 3.

20.

Noggin4 is a long-range inhibitor of Wnt8 signalling that regulates head development in Xenopus laevis.

Eroshkin FM, Nesterenko AM, Borodulin AV, Martynova NY, Ermakova GV, Gyoeva FK, Orlov EE, Belogurov AA, Lukyanov KA, Bayramov AV, Zaraisky AG.

Sci Rep. 2016 Mar 14;6:23049. doi: 10.1038/srep23049.

21.

Modified siRNA effectively silence inducible immunoproteasome subunits in NSO cells.

Gvozdeva OV, Belogurov AA Jr, Kuzina ES, Gabibov AG, Meschaninova MI, Ven'yaminova AG, Zenkova MA, Vlassov VV, Chernolovskaya EL.

Biochimie. 2016 Jun;125:75-82. doi: 10.1016/j.biochi.2016.02.015. Epub 2016 Mar 2.

PMID:
26944796
22.

Chemical Polysialylation and In Vivo Tetramerization Improve Pharmacokinetic Characteristics of Recombinant Human Butyrylcholinesterase-Based Bioscavengers.

Terekhov SS, Smirnov IV, Shamborant OG, Bobik TV, Ilyushin DG, Murashev AN, Dyachenko IA, Palikov VA, Knorre VD, Belogurov AA, Ponomarenko NA, Kuzina ES, Genkin DD, Masson P, Gabibov AG.

Acta Naturae. 2015 Oct-Dec;7(4):136-41.

23.

Specific Depletion of Myelin-Reactive B Cells via BCR-Targeting.

Stepanov AV, Belogurov AA Jr, Kothapalli P, Shamborant OG, Knorre VD, Telegin GB, Ovsepyan AA, Ponomarenko NA, Deyev SM, Kaveri SV, Gabibov AG.

Acta Naturae. 2015 Apr-Jun;7(2):74-9.

24.

Chemical Polysialylation of Recombinant Human Proteins.

Smirnov IV, Vorobiev II, Belogurov AA, Genkin DD, Deyev SM, Gabibov AG.

Methods Mol Biol. 2015;1321:389-404. doi: 10.1007/978-1-4939-2760-9_26.

PMID:
26082236
25.

Excessive Labeling Technique Provides a Highly Sensitive Fluorescent Probe for Real-time Monitoring of Biodegradation of Biopolymer Pharmaceuticals in vivo.

Terekhov SS, Smirnov IV, Shamborant OG, Zenkova MA, Chernolovskaya EL, Gladkikh DV, Murashev AN, Dyachenko IA, Knorre VD, Belogurov AA, Ponomarenko NA, Deyev SM, Vlasov VV, Gabibov AG.

Acta Naturae. 2014 Oct;6(4):54-9.

26.

Heavy-light chain interrelations of MS-associated immunoglobulins probed by deep sequencing and rational variation.

Lomakin YA, Zakharova MY, Stepanov AV, Dronina MA, Smirnov IV, Bobik TV, Pyrkov AY, Tikunova NV, Sharanova SN, Boitsov VM, Vyazmin SY, Kabilov MR, Tupikin AE, Krasnov AN, Bykova NA, Medvedeva YA, Fridman MV, Favorov AV, Ponomarenko NA, Dubina MV, Boyko AN, Vlassov VV, Belogurov AA Jr, Gabibov AG.

Mol Immunol. 2014 Dec;62(2):305-14. doi: 10.1016/j.molimm.2014.01.013. Epub 2014 Feb 16.

27.

Polyreactive monoclonal autoantibodies in multiple sclerosis: functional selection from phage display library and characterization by deep sequencing analysis.

Lomakin YA, Zakharova MY, Belogurov AA, Bykova NA, Dronina MA, Tupikin AE, Knorre VD, Boyko AN, Favorov AV, Kabilov MR, Ponomarenko NA, Gabibov G.

Acta Naturae. 2013 Oct;5(4):94-104.

28.

Immunoproteasome enhances intracellular proteolysis of myelin basic protein.

Kuzina ES, Chernolovskaya EL, Kudriaeva AA, Zenkova MA, Knorre VD, Surina EA, Ponomarenko NA, Bobik TV, Smirnov IV, Bacheva AV, Belogurov AA, Gabibov AG, Vlasov VV.

Dokl Biochem Biophys. 2013 Nov;453:300-3. doi: 10.1134/S1607672913060070. Epub 2014 Jan 3. No abstract available.

PMID:
24385101
29.

Chemical polysialylation of human recombinant butyrylcholinesterase delivers a long-acting bioscavenger for nerve agents in vivo.

Ilyushin DG, Smirnov IV, Belogurov AA Jr, Dyachenko IA, Zharmukhamedova TIu, Novozhilova TI, Bychikhin EA, Serebryakova MV, Kharybin ON, Murashev AN, Anikienko KA, Nikolaev EN, Ponomarenko NA, Genkin DD, Blackburn GM, Masson P, Gabibov AG.

Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1243-8. doi: 10.1073/pnas.1211118110. Epub 2013 Jan 7.

30.

Creation of catalytic antibodies metabolizing organophosphate compounds.

Kurkova IN, Smirnov IV, Belogurov AA Jr, Ponomarenko NA, Gabibov AG.

Biochemistry (Mosc). 2012 Oct;77(10):1139-46. doi: 10.1134/S0006297912100069. Review.

31.

Liposome-encapsulated peptides protect against experimental allergic encephalitis.

Belogurov AA Jr, Stepanov AV, Smirnov IV, Melamed D, Bacon A, Mamedov AE, Boitsov VM, Sashchenko LP, Ponomarenko NA, Sharanova SN, Boyko AN, Dubina MV, Friboulet A, Genkin DD, Gabibov AG.

FASEB J. 2013 Jan;27(1):222-31. doi: 10.1096/fj.12-213975. Epub 2012 Oct 9.

32.

[Therapeutic effect of encapsulated into the nanocontainers MBP immunodominant peptides on EAE development in DA rats].

Stepanov AV, Belogurov AA, Mamedov AÉ, Melamed D, Smirnov IV, Kuzina ES, Genkin DD, Boĭko AN, Sharanova SN, Bacon A, Ponomarenko NA, Gabibov AG.

Bioorg Khim. 2012 May-Jun;38(3):306-14. Russian.

PMID:
22997702
33.

Extracellular HspBP1 inhibits formation of a cytotoxic Tag7-Hsp70 complex in vitro and in human serum.

Yashin DV, Dukhanina EA, Kabanova OD, Romanova EA, Lukyanova TI, Tonevitskii AG, Belogurov AA, Raynes DA, Sheludchenkov AA, Gnuchev NV, Guerriero V, Georgiev GP, Sashchenko LP.

Biochimie. 2012 Jan;94(1):203-6. doi: 10.1016/j.biochi.2011.10.007. Epub 2011 Oct 21.

PMID:
22037021
34.

Reactibodies generated by kinetic selection couple chemical reactivity with favorable protein dynamics.

Smirnov I, Carletti E, Kurkova I, Nachon F, Nicolet Y, Mitkevich VA, Débat H, Avalle B, Belogurov AA Jr, Kuznetsov N, Reshetnyak A, Masson P, Tonevitsky AG, Ponomarenko N, Makarov AA, Friboulet A, Tramontano A, Gabibov A.

Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15954-9. doi: 10.1073/pnas.1108460108. Epub 2011 Sep 6.

35.

Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen.

Gabibov AG, Belogurov AA Jr, Lomakin YA, Zakharova MY, Avakyan ME, Dubrovskaya VV, Smirnov IV, Ivanov AS, Molnar AA, Gurtsevitch VE, Diduk SV, Smirnova KV, Avalle B, Sharanova SN, Tramontano A, Friboulet A, Boyko AN, Ponomarenko NA, Tikunova NV.

FASEB J. 2011 Dec;25(12):4211-21. doi: 10.1096/fj.11-190769. Epub 2011 Aug 22.

PMID:
21859892
36.

Design of targeted B cell killing agents.

Stepanov AV, Belogurov AA Jr, Ponomarenko NA, Stremovskiy OA, Kozlov LV, Bichucher AM, Dmitriev SE, Smirnov IV, Shamborant OG, Balabashin DS, Sashchenko LP, Tonevitsky AG, Friboulet A, Gabibov AG, Deyev SM.

PLoS One. 2011;6(6):e20991. doi: 10.1371/journal.pone.0020991. Epub 2011 Jun 6.

37.

[Expression of the catalytic antibodies in eukaryotic systems].

Zakharov AV, Smirnov IV, Serebriakova MV, Dronina MA, Kaznacheeva AV, Kurkova IN, Belogurov AA, Friboulet A, Ponomarenko NA, Gabibov AG, Bobik TV.

Mol Biol (Mosk). 2011 Jan-Feb;45(1):86-95. Russian.

PMID:
21485500
38.

[Functional degradation of myelin basic protein. Proteomic approach].

Bacheva AV, Belogurov AA, Kuzina ES, Serebriakova MV, Ponomarenko NA, Knorre VD, Govorun VM, Gabibov AG.

Bioorg Khim. 2011 Jan-Feb;37(1):45-54. Russian.

PMID:
21460880
39.

[Surgical treatment policy using recombinant prourokinase for submacular hemorrhages].

Sosnovskiĭ VV, Sdobnikova SV, Revishchin AV, Surguch VK, Troitskaia NA, Sidamonidze AL, Belogurov AA, Del'ver EP, Gurskiĭ IaG.

Vestn Oftalmol. 2009 Jul-Aug;125(4):3-8. Russian.

PMID:
19824437
40.

Suppression of ongoing experimental allergic encephalomyelitis in DA rats by novel peptide drug, structural part of human myelin basic protein 46-62.

Belogurov AA Jr, Zargarova TA, Turobov VI, Novikova NI, Favorova OO, Ponomarenko NA, Gabibov AG.

Autoimmunity. 2009 May;42(4):362-4.

PMID:
19811302
41.

Site-specific degradation of myelin basic protein by the proteasome.

Belogurov AA Jr, Ponomarenko NA, Govorun VM, Gabibov AG, Bacheva AV.

Dokl Biochem Biophys. 2009 Mar-Apr;425:68-72. No abstract available.

PMID:
19496324
42.

Analysis of myelin basic protein fragmentation by proteasome.

Bacheva AV, Belogurov AA, Ponomarenko NA, Knorre VD, Govorun VM, Serebryakova MV, Gabibov AG.

Acta Naturae. 2009 Apr;1(1):84-7.

43.

[Local fibrinolysis of hypertensive intracerebral hematomas].

Saribekian AS, Arzamastsev EV, Bibilashvili RSh, Golubykh VL, Belogurov AA, Poliakova LN, Ponomarev VA.

Zh Vopr Neirokhir Im N N Burdenko. 2008 Jul-Sep;(3):14-9; discussion 19-20. Russian.

PMID:
19062590
44.

Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.

Belogurov AA Jr, Kurkova IN, Friboulet A, Thomas D, Misikov VK, Zakharova MY, Suchkov SV, Kotov SV, Alehin AI, Avalle B, Souslova EA, Morse HC 3rd, Gabibov AG, Ponomarenko NA.

J Immunol. 2008 Jan 15;180(2):1258-67.

45.

Substrate specificity of catalytic autoantibodies in neurodegenerative processes.

Belogurov AA, Kurkova IN, Misikov VK, Suchkov SV, Telegin GB, Alekhine AI, Goncharov NG, Knorre VD, Gabibov AG, Ponomarenko NA.

Dokl Biochem Biophys. 2007 Mar-Apr;413:61-4. No abstract available.

PMID:
17546954
46.

Plasmid-encoded antirestriction protein ArdA can discriminate between type I methyltransferase and complete restriction-modification system.

Nekrasov SV, Agafonova OV, Belogurova NG, Delver EP, Belogurov AA.

J Mol Biol. 2007 Jan 12;365(2):284-97. Epub 2006 Oct 4.

PMID:
17069852
47.

Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen.

Ponomarenko NA, Durova OM, Vorobiev II, Belogurov AA Jr, Kurkova IN, Petrenko AG, Telegin GB, Suchkov SV, Kiselev SL, Lagarkova MA, Govorun VM, Serebryakova MV, Avalle B, Tornatore P, Karavanov A, Morse HC 3rd, Thomas D, Friboulet A, Gabibov AG.

Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):281-6. Epub 2005 Dec 30.

48.

Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale.

Ponomarenko NA, Durova OM, Vorobiev II, Belogurov AA, Telegin GB, Suchkov SV, Misikov VK, Morse HC 3rd, Gabibov AG.

Immunol Lett. 2006 Feb 28;103(1):45-50. Epub 2005 Nov 4.

PMID:
16297986
49.

[Prospects for treating intraocular traumatic hemorrhage using a new fibrinolytic hemase].

Stepanov AV, Bolkvadze ER, Belogurov AA, Tovarova II.

Vestn Oftalmol. 2002 Sep-Oct;118(5):25-7. Russian.

PMID:
12532741
50.

[Mutational analysis of the conserved motif of the Arda anti-restriction protein encoded by self-transmissible IncI plasmid ColIb-p9].

Del'ver EP, Sobennikova MV, Belogurova NG, Nekrasov SV, Kolesnikova MD, Agafonova OV, Belogurov AA.

Mol Biol (Mosk). 2002 Nov-Dec;36(6):1062-7. Russian.

PMID:
12500545

Supplemental Content

Loading ...
Support Center